Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suresh Senan

Showing results (111-120 of 347) with videos related to

Pageof 35
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 6, 2007
Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?Cornelis J A Haasbeek, Frank J Lagerwaard, Johan P Cuijpers, et al.
Clinical Lung Cancer|October 27, 2015
Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-AnalysisDavid A Palma, Andrew Warner, Alexander V Louie, et al.
Cancer|January 9, 2009
Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomyCornelis J A Haasbeek, Frank J Lagerwaard, Katrien de Jaeger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2011
Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancerEva M Bongers, Cornelis J A Haasbeek, Frank J Lagerwaard, et al.
Cancer|December 2, 2009
Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapyCornelis J A Haasbeek, Frank J Lagerwaard, Marilisa E Antonisse, et al.
Journal of Geriatric Oncology|May 17, 2021
Age-related treatment patterns for stage I NSCLC in three European countriesRonald A M Damhuis, Suresh Senan, Aamir Khakwani, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasetsRené W M Underberg, Frank J Lagerwaard, Ben J Slotman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicityChin Loon Ong, David Palma, Wilko F A R Verbakel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2011
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven diseaseNaomi E Verstegen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2015
Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerationsAlexander V Louie, Suresh Senan, Max Dahele, et al.
Pageof 35

Showing results (111-120 of 347) with videos related to

Sort By:
Pageof 35
International Journal of Radiation Oncology, Biology, Physics|February 6, 2007
Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?Cornelis J A Haasbeek, Frank J Lagerwaard, Johan P Cuijpers, et al.
Clinical Lung Cancer|October 27, 2015
Thoracic Radiotherapy for Extensive Stage Small-Cell Lung Cancer: A Meta-AnalysisDavid A Palma, Andrew Warner, Alexander V Louie, et al.
Cancer|January 9, 2009
Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomyCornelis J A Haasbeek, Frank J Lagerwaard, Katrien de Jaeger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2011
Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancerEva M Bongers, Cornelis J A Haasbeek, Frank J Lagerwaard, et al.
Cancer|December 2, 2009
Stage I nonsmall cell lung cancer in patients aged > or =75 years: outcomes after stereotactic radiotherapyCornelis J A Haasbeek, Frank J Lagerwaard, Marilisa E Antonisse, et al.
Journal of Geriatric Oncology|May 17, 2021
Age-related treatment patterns for stage I NSCLC in three European countriesRonald A M Damhuis, Suresh Senan, Aamir Khakwani, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2005
Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasetsRené W M Underberg, Frank J Lagerwaard, Ben J Slotman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 26, 2010
Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicityChin Loon Ong, David Palma, Wilko F A R Verbakel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 8, 2011
Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven diseaseNaomi E Verstegen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 2015
Stereotactic ablative radiation therapy for subcentimeter lung tumors: clinical, dosimetric, and image guidance considerationsAlexander V Louie, Suresh Senan, Max Dahele, et al.
Pageof 35